The reputation of the best drugs, whether unofficial or official, is bound to suffer if extravagant claims for them are permitted to go unchallenged. The referee of the Council, therefore, believed it necessary to call the attention of the manufacturers of Alcresta Ipecac Tablets to the statements made for the product and suggested that they submit evidence to substantiate the claims. This the manufacturers have refused to do. Their attitude in the matter, as well as their attitude toward the Council’s work is expressed in the following letter: “Responding to your letter of March 10th, we beg to suggest that literature covering the different matters at issue are readily available to your referee, and all statements emanating from us are made advisedly. “If you cannot satisfy yourselves that this preparation is a scientific product, ethically advertised, and a desirable advance in therapeutics, you can only delete it from your next issue of New and Nonofficial Remedies.” It is to be regretted that Eli Lilly and Co. refuse either to withdraw or modify their claims or to substantiate these claims by scientific evidence. The statements as they stand are exaggerated, misleading and harmful. As such they conflict with Rule 6 of the Council and necessitate the omission of Alcresta Ipecac from New and Nonofficial Remedies. The referee recommended the adoption and publication of this report.--(_From The Journal A. M. A., Oct. 20, 1917._) IODEOL AND IODAGOL Report of the Council on Pharmacy and Chemistry Iodeol and Iodagol (formerly called Iodargol) are products of Viel and Company, Rennes, France, widely advertised in this country by David B. Levy, Incorporated, New York. The claim made for both preparations is that they depend on “colloidal iodin” for their action. They are put up in a number of forms, for instance: “Iodeol Ampoules each containing 1 c.c. (20 centigrammes colloidal iodin in an oily vehicle).” “Iodeol External, containing 50 per cent. colloidal iodine.” “Iodagol Ampoules, each containing 2 c.c. (50 centigrammes colloidal iodine in an oily vehicle).” The claim is, that, the iodin being in the colloidal state, it has the properties of elementary iodin and thus the preparations may be used in concentrations and under conditions which would make the use of free iodin impossible. The products have been extensively and extravagantly advertised for use in a wide range of conditions. Thus Iodeol has been proposed in the treatment of: “Pulmonary Tuberculosis” “Laryngeal Tuberculosis,” “Glandular Tuberculosis” “Tuberculosis of the Bones” “Pneumonia, Broncho-pneumonia, and Congestive Conditions” “Whooping Cough, Influenza, Asthma” “Typhoid Fever” “Syphilis” “Obesity.” Iodagol, which is for external use, has been advised in the treatment of: